Oncology PracticeStudy found long-term benefit of nivolumab for advanced melanoma patientsApril 18, 2016Melanoma
Oncology PracticeTargeted therapy, immunotherapy may benefit patients with leptomeningeal metastases from melanomaApril 5, 2016Melanoma
Oncology PracticeDoes sharing genetic risk change behavior?March 23, 2016Lung CancerPreventive CareMelanoma
Oncology PracticeItraconazole targets basal cell carcinomaMarch 10, 2016MelanomaNonmelanoma Skin Cancer
Oncology PracticeRECIST underestimates benefit of pembrolizumab in subset of melanoma patientsMarch 7, 2016Melanoma
Hematology NewsChildren who have stem cell transplants need skin exams, sun protectionMarch 7, 2016MelanomaPediatricsCellular TherapyLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology NewsIbrutinib bodes well for relapsed mantle-cell lymphomaMarch 2, 2016Mantle Cell LymphomaLymphoma & Plasma Cell DisordersMelanoma
Oncology PracticeVIDEO: Genetic tests, clinical data sharpen pigmented lesion diagnosisFebruary 26, 2016Melanoma
The Journal of Community and Supportive OncologySecond targeted combination regime approved for metastatic melanoma February 21, 2016Melanoma
Oncology PracticeHigh-dose interferon offered no survival benefit in patients with melanoma and a single tumor–positive sentinel lymph nodeFebruary 8, 2016Melanoma
Oncology PracticeWho among us has not asked a patient to keep track of a mole?February 7, 2016Melanoma
